SCHEMBL7637533

SCHEMBL7637533

CC(NCc1ccccc1Cl)C(O)c1ccccc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.72
KMT2A Q03164 5/20 0.72
CYP2D6 P10635 3/20 0.72
CYP2C19 P33261 3/20 0.72
CYP1A2 P05177 2/20 0.72
CYP3A4 P08684 2/20 0.72
CYP2C9 P11712 2/20 0.72
LMNA P02545 4/20 0.56
MAPK1 P28482 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
ALDH1A1 P00352 1/20 0.56
HTT P42858 1/20 0.56
KDM4E B2RXH2 1/20 0.52
POLB P06746 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CASR P41180 2/20 0.50
CHRM2 P08172 1/20 0.50
ADRA1A P35348 1/20 0.50
RGS12 O14924 1/20 0.50
GLA P06280 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7637536 1.00 MEN1 (0.72) MEN1KMT2ACYP2D6CYP2C19CYP1A2
SCHEMBL9097239 0.83 LMNA (0.60) MEN1KMT2ACYP2D6CYP2C19CYP1A2
SCHEMBL7637540 0.83 KMT2A (0.58) MEN1KMT2ACYP2D6CYP2C19CYP1A2
SCHEMBL7637544 0.83 KMT2A (0.58) MEN1KMT2ACYP2D6CYP2C19CYP1A2
SCHEMBL11446037 0.82 MEN1 (0.58) MEN1KMT2ACYP2D6CYP2C19CYP1A2
Hydrochloric Acid SCHEMBL11696689 0.81 MEN1 (0.60) MEN1KMT2ACYP2D6CYP2C19CYP1A2
SCHEMBL2168291 0.80 CASR (0.67) MEN1KMT2ACYP2D6CYP2C19CYP1A2
SCHEMBL4074646 0.80 CASR (0.67) MEN1KMT2ACYP2D6CYP2C19CYP1A2
SCHEMBL27535379 0.80 CASR (0.67) MEN1KMT2ACYP2D6CYP2C19CYP1A2
SCHEMBL7637808 0.79 ATM (0.66) MEN1KMT2ACYP2D6CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020193347-A1 Using an optically active N-substituted chiral derivative of norephedrine as ligand for enantioselective reduction of unsaturated compounds carrying functional groups by a hydrogen transfer method PPG-SIPSY, A CORPORATION OF FRANCE (FR) 2002-12-19 US claimed
US-20020193347-A1 Using an optically active N-substituted chiral derivative of norephedrine as ligand for enantioselective reduction of unsaturated compounds carrying functional groups by a hydrogen transfer method PPG-SIPSY, A CORPORATION OF FRANCE (FR) 2002-12-19 US disclosed